Hepatitis C virus-positive human liver cirrhosis patient liver cancer occurrence / proliferation inhibitor

摘要

The present invention relates to a hepatitis C virus-positive human cirrhosis patient comprising hepatitis C virus-positive human cirrhosis consisting of three amino acids, isoleucine, leucine and valine, as a drug having an effect of suppressing the occurrence and / or progression of liver cancer in hepatitis C virus-positive human cirrhosis patient. A liver cancer occurrence and / or progression inhibitor is provided.